Finally, as NFIB is expressed by GBM cells including GBM cancer stem/tumour-initiating cells [71], and is rarely homozygously deleted or mutated [27], it may have therapeutic benefit in GBM if its expression can be increased. This evidence concerns the gene NFIB and cancer.